Financhill
Buy
54

LMT Quote, Financials, Valuation and Earnings

Last price:
$468.30
Seasonality move :
2.95%
Day range:
$469.34 - $474.49
52-week range:
$418.88 - $618.95
Dividend yield:
2.74%
P/E ratio:
20.37x
P/S ratio:
1.56x
P/B ratio:
16.53x
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
2.09%
Market cap:
$110.5B
Revenue:
$71B
EPS (TTM):
$23.15
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $65.4B $67B $66B $67.6B $71B
Revenue Growth (YoY) 9.34% 2.52% -1.58% 2.41% 5.14%
 
Cost of Revenues $56.7B $58B $57.7B $59.1B $64.1B
Gross Profit $8.7B $9.1B $8.3B $8.5B $6.9B
Gross Profit Margin 13.23% 13.52% 12.56% 12.55% 9.76%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $182M -$1B -$1B $507M $243M
Operating Expenses $10M -$62M -$61M -$28M -$83M
Operating Income $8.6B $9.1B $8.3B $8.5B $7B
 
Net Interest Expenses $591M $569M $623M $916M $1B
EBT. Incl. Unusual Items $8.2B $7.6B $6.7B $8.1B $6.2B
Earnings of Discontinued Ops. -$55M -- -- -- --
Income Tax Expense $1.3B $1.2B $948M $1.2B $884M
Net Income to Company $6.8B $6.3B $5.7B $6.9B $5.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.8B $6.3B $5.7B $6.9B $5.3B
 
Basic EPS (Cont. Ops) $24.40 $22.85 $21.74 $27.65 $22.39
Diluted EPS (Cont. Ops) $24.30 $22.76 $21.66 $27.55 $22.31
Weighted Average Basic Share $280M $276.4M $263.7M $250.3M $238.3M
Weighted Average Diluted Share $281.2M $277.4M $264.6M $251.2M $239.2M
 
EBITDA $10.1B $9.5B $8.7B $10.4B $8.8B
EBIT $8.8B $8.1B $7.3B $9B $7.3B
 
Revenue (Reported) $65.4B $67B $66B $67.6B $71B
Operating Income (Reported) $8.6B $9.1B $8.3B $8.5B $7B
Operating Income (Adjusted) $8.8B $8.1B $7.3B $9B $7.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $16.3B $15B $15.1B $17.2B $18B
Revenue Growth (YoY) 3.88% -7.96% 1.08% 13.68% 4.47%
 
Cost of Revenues $14.1B $13.1B $13.1B $15.2B $15.6B
Gross Profit $2.2B $1.9B $2B $2B $2.3B
Gross Profit Margin 13.45% 12.76% 13.53% 11.59% 12.93%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -$110M -- --
Other Inc / (Exp) $165M $263M $159M $61M -$68M
Operating Expenses -- -$24M $9M -$36M -$49M
Operating Income $2.2B $1.9B $2B $2B $2.4B
 
Net Interest Expenses $140M $135M $202M $255M $268M
EBT. Incl. Unusual Items $2.2B $2.1B $2B $1.8B $2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $374M $328M $305M $290M $324M
Net Income to Company $1.8B $1.7B $1.7B $1.5B $1.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $1.7B $1.7B $1.5B $1.7B
 
Basic EPS (Cont. Ops) $6.58 $6.46 $6.63 $6.42 $7.30
Diluted EPS (Cont. Ops) $6.56 $6.44 $6.61 $6.39 $7.28
Weighted Average Basic Share $279M $268.3M $254.7M $240.7M $234.4M
Weighted Average Diluted Share $280M $269.2M $255.7M $241.6M $235.3M
 
EBITDA $2.7B $2.5B $2.5B $2.4B $2.7B
EBIT $2.4B $2.2B $2.2B $2.1B $2.3B
 
Revenue (Reported) $16.3B $15B $15.1B $17.2B $18B
Operating Income (Reported) $2.2B $1.9B $2B $2B $2.4B
Operating Income (Adjusted) $2.4B $2.2B $2.2B $2.1B $2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $66B $65.8B $66.1B $69.6B $71.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $57.3B $57B $57.7B $61.2B $64.6B
Gross Profit $8.7B $8.8B $8.4B $8.4B $7.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $260M -$947M -$1.1B $298M $99M
Operating Expenses -- -- -$28M -$184M -$111M
Operating Income $8.7B $8.9B $8.5B $8.6B $7.4B
 
Net Interest Expenses $583M $564M $690M $969M $1B
EBT. Incl. Unusual Items $8.4B $7.4B $6.6B $7.9B $6.4B
Earnings of Discontinued Ops. -$55M -- -- -- --
Income Tax Expense $1.4B $1.2B $925M $1.2B $918M
Net Income to Company $7B $6.2B $5.7B $6.8B $5.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7B $6.2B $5.7B $6.8B $5.5B
 
Basic EPS (Cont. Ops) $24.88 $22.72 $21.96 $27.43 $23.23
Diluted EPS (Cont. Ops) $24.78 $22.64 $21.88 $27.33 $23.15
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $10.3B $9.3B $8.7B $10.4B $9.1B
EBIT $9B $8B $7.3B $8.9B $7.5B
 
Revenue (Reported) $66B $65.8B $66.1B $69.6B $71.8B
Operating Income (Reported) $8.7B $8.9B $8.5B $8.6B $7.4B
Operating Income (Adjusted) $9B $8B $7.3B $8.9B $7.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $16.3B $15B $15.1B $17.2B $18B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $14.1B $13.1B $13.1B $15.2B $15.6B
Gross Profit $2.2B $1.9B $2B $2B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -$110M -- --
Other Inc / (Exp) $165M $263M $159M $61M -$68M
Operating Expenses -- -$24M $9M -$36M -$49M
Operating Income $2.2B $1.9B $2B $2B $2.4B
 
Net Interest Expenses $140M $135M $202M $255M $268M
EBT. Incl. Unusual Items $2.2B $2.1B $2B $1.8B $2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $374M $328M $305M $290M $324M
Net Income to Company $1.8B $1.7B $1.7B $1.5B $1.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $1.7B $1.7B $1.5B $1.7B
 
Basic EPS (Cont. Ops) $6.58 $6.46 $6.63 $6.42 $7.30
Diluted EPS (Cont. Ops) $6.56 $6.44 $6.61 $6.39 $7.28
Weighted Average Basic Share $279M $268.3M $254.7M $240.7M $234.4M
Weighted Average Diluted Share $280M $269.2M $255.7M $241.6M $235.3M
 
EBITDA $2.7B $2.5B $2.5B $2.4B $2.7B
EBIT $2.4B $2.2B $2.2B $2.1B $2.3B
 
Revenue (Reported) $16.3B $15B $15.1B $17.2B $18B
Operating Income (Reported) $2.2B $1.9B $2B $2B $2.4B
Operating Income (Adjusted) $2.4B $2.2B $2.2B $2.1B $2.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3.2B $3.6B $2.5B $1.4B $2.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2B $2B $2.5B $2.1B $2.4B
Inventory $3.5B $3B $3.1B $3.1B $3.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.2B $688M $533M $632M $584M
Total Current Assets $19.4B $19.8B $21B $20.5B $21.8B
 
Property Plant And Equipment $7.2B $7.6B $8B $8.4B $8.7B
Long-Term Investments -- -- -- -- --
Goodwill $10.8B $10.8B $10.8B $10.8B $11.1B
Other Intangibles $3B $2.7B $2.5B $2.2B $2B
Other Long-Term Assets $6.8B $7.7B $6.9B $7.6B $8.4B
Total Assets $50.7B $50.9B $52.9B $52.5B $55.6B
 
Accounts Payable $880M $780M $2.1B $2.3B $2.2B
Accrued Expenses $3.2B $3.1B $3.1B $3.1B $3.1B
Current Portion Of Long-Term Debt $500M -- $118M $168M $643M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.8B $2B $2.1B $2.1B $3.6B
Total Current Liabilities $13.9B $14B $15.9B $16.9B $19.4B
 
Long-Term Debt $11.7B $11.7B $15.4B $17.3B $19.6B
Capital Leases -- -- -- -- --
Total Liabilities $44.7B $39.9B $43.6B $45.6B $49.3B
 
Common Stock $279M $271M $254M $240M $234M
Other Common Equity Adj -$16.1B -$11B -$8B -$8.8B -$8.5B
Common Equity $6B $11B $9.3B $6.8B $6.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $23M -- -- -- --
Total Equity $6B $11B $9.3B $6.8B $6.3B
 
Total Liabilities and Equity $50.7B $50.9B $52.9B $52.5B $55.6B
Cash and Short Terms $3.2B $3.6B $2.5B $1.4B $2.5B
Total Debt $12.2B $11.7B $15.5B $17.5B $20.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $2.9B $1.9B $2.4B $2.8B $1.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.2B $2.5B $2.6B $2.3B $2B
Inventory $3.3B $3.1B $3.5B $3.3B $3.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $941M $706M $461M $583M $698M
Total Current Assets $20.3B $20.4B $22.1B $23B $22.8B
 
Property Plant And Equipment $7.2B $7.6B $7.9B $8.4B $8.7B
Long-Term Investments -- -- -- -- --
Goodwill $10.8B $10.8B $10.8B $10.8B $11.1B
Other Intangibles $2.9B $2.6B $2.4B $2.2B $2B
Other Long-Term Assets $6.9B $7.4B $7.2B $7.7B $8.6B
Total Assets $51.4B $51.5B $54.6B $55B $56.7B
 
Accounts Payable $1.9B $2.6B $3.3B $3.5B $3.8B
Accrued Expenses $2.8B $2.7B $2.6B $2.7B $2.4B
Current Portion Of Long-Term Debt -- -- -- $168M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.3B $2.4B $2.6B $2.6B $4B
Total Current Liabilities $14.7B $16B $17B $17.7B $21.2B
 
Long-Term Debt $11.7B $11.1B $15.5B $19.3B $18.7B
Capital Leases -- -- -- -- --
Total Liabilities $45.1B $41.5B $45B $48.3B $50B
 
Common Stock $278M $265M $254M $239M $233M
Other Common Equity Adj -$16B -$11B -$8.1B -$8.8B -$8.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $21M -- -- -- --
Total Equity $6.3B $10B $9.6B $6.7B $6.7B
 
Total Liabilities and Equity $51.4B $51.5B $54.6B $55B $56.7B
Cash and Short Terms $2.9B $1.9B $2.4B $2.8B $1.8B
Total Debt $12.2B $11.6B $15.6B $19.4B $20.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $6.8B $6.3B $5.7B $6.9B $5.3B
Depreciation & Amoritzation $1.3B $1.4B $1.4B $1.4B $1.6B
Stock-Based Compensation $221M $227M $238M $265M $277M
Change in Accounts Receivable -$92M -$1B -$2.3B -$492M -$328M
Change in Inventories $74M $564M -$107M -$44M -$478M
Cash From Operations $8.2B $9.2B $7.8B $7.9B $7B
 
Capital Expenditures $1.8B $1.5B $1.7B $1.7B $1.7B
Cash Acquisitions -$282M -- -- -- --
Cash From Investing -$2B -$1.2B -$1.8B -$1.7B -$1.8B
 
Dividends Paid (Ex Special Dividend) -$2.8B -$2.9B -$3B -$3.1B -$3.1B
Special Dividend Paid
Long-Term Debt Issued $1.1B -- $6.2B $2B $3B
Long-Term Debt Repaid -$1.7B -$500M -$2.3B -$115M -$168M
Repurchase of Common Stock -$1.1B -$4.1B -$7.9B -$6B -$3.7B
Other Financing Activities -$144M -$89M -$115M -$135M -$182M
Cash From Financing -$4.5B -$7.6B -$7.1B -$7.3B -$4.1B
 
Beginning Cash (CF) $1.5B $3.2B $3.6B $2.5B $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B $444M -$1.1B -$1.1B $1B
Ending Cash (CF) $3.2B $3.6B $2.5B $1.4B $2.5B
 
Levered Free Cash Flow $6.4B $7.7B $6.1B $6.2B $5.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.8B $1.7B $1.7B $1.5B $1.7B
Depreciation & Amoritzation $336M $329M $325M $351M $397M
Stock-Based Compensation $47M $54M $57M $61M $60M
Change in Accounts Receivable -$1.6B -$2.1B -$949M -$992M -$1.4B
Change in Inventories $289M -$163M -$383M -$146M -$125M
Cash From Operations $1.7B $1.4B $1.6B $1.6B $1.4B
 
Capital Expenditures $281M $268M $294M $378M $454M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$169M -$251M -$259M -$372M -$430M
 
Dividends Paid (Ex Special Dividend) -$739M -$767M -$784M -$780M -$796M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2B --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$1B -$2B -$500M -$1B -$750M
Other Financing Activities -$67M -$113M -$128M -$115M -$113M
Cash From Financing -$1.8B -$2.9B -$1.4B $85M -$1.7B
 
Beginning Cash (CF) $3.2B $3.6B $2.5B $1.4B $2.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$227M -$1.7B -$107M $1.3B -$680M
Ending Cash (CF) $2.9B $1.9B $2.4B $2.8B $1.8B
 
Levered Free Cash Flow $1.5B $1.1B $1.3B $1.3B $955M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $7B $6.2B $5.7B $6.8B $5.5B
Depreciation & Amoritzation $1.3B $1.4B $1.4B $1.5B $1.6B
Stock-Based Compensation $226M $234M $241M $269M $276M
Change in Accounts Receivable -$41M -$1.5B -$1.1B -$535M -$729M
Change in Inventories $283M $112M -$327M $193M -$457M
Cash From Operations $7.6B $8.9B $8B $8B $6.7B
 
Capital Expenditures $1.8B $1.5B $1.7B $1.8B $1.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.9B -$1.2B -$1.8B -$1.8B -$1.9B
 
Dividends Paid (Ex Special Dividend) -$2.8B -$3B -$3B -$3.1B -$3.1B
Special Dividend Paid
Long-Term Debt Issued -- -- $6.2B $4B $990M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$1.3B -$5.1B -$6.4B -$6.5B -$3.5B
Other Financing Activities -$115M -$135M -$130M -$122M -$180M
Cash From Financing -$4.8B -$8.7B -$5.6B -$5.8B -$5.9B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $945M -$1.1B $557M $350M -$987M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $5.9B $7.4B $6.3B $6.2B $5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.8B $1.7B $1.7B $1.5B $1.7B
Depreciation & Amoritzation $336M $329M $325M $351M $397M
Stock-Based Compensation $47M $54M $57M $61M $60M
Change in Accounts Receivable -$1.6B -$2.1B -$949M -$992M -$1.4B
Change in Inventories $289M -$163M -$383M -$146M -$125M
Cash From Operations $1.7B $1.4B $1.6B $1.6B $1.4B
 
Capital Expenditures $281M $268M $294M $378M $454M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$169M -$251M -$259M -$372M -$430M
 
Dividends Paid (Ex Special Dividend) -$739M -$767M -$784M -$780M -$796M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2B --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$1B -$2B -$500M -$1B -$750M
Other Financing Activities -$67M -$113M -$128M -$115M -$113M
Cash From Financing -$1.8B -$2.9B -$1.4B $85M -$1.7B
 
Beginning Cash (CF) $3.2B $3.6B $2.5B $1.4B $2.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$227M -$1.7B -$107M $1.3B -$680M
Ending Cash (CF) $2.9B $1.9B $2.4B $2.8B $1.8B
 
Levered Free Cash Flow $1.5B $1.1B $1.3B $1.3B $955M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock